Current kidney cancer research
Help us beat cancer sooner
Our life-saving work relies on the money you give us.
Donate now and together we can save more lives by beating cancer sooner.
Saving lives through our research
More people than ever are being diagnosed with kidney cancer, so our researchers are working hard to better understand what increases the risk of kidney cancer. Our researchers are also studying kidney cancer biology and developing new treatments to improve the outlook for people diagnosed with this type of cancer.
Our current researchers
Looking at a genetic 'patchwork'
Dr Samra Turajlic at the Francis Crick Institute in London is looking in detail at the genetic ‘patchwork’ inside kidney tumours. Through a study called TRACERx Renal she’s mapping how the genetic makeup of kidney tumours changes over time and how treatment affects this ‘patchwork’ of genetic changes.
Finding new drug targets
At our Beatson Institute in Glasgow, Professor Eyal Gottlieb is searching for differences in how kidney cancer cells and healthy cells generate and use energy. He wants to work out how to exploit these differences to try and find powerful new ways to treat the disease. His work has already thrown up exciting potential leads for new drugs.
Testing new treatments
In Cambridge, Professor Tim Eisen is developing and testing new treatments for kidney cancer. He is currently running a large clinical trial called SORCE, to find out whether giving people with kidney cancer a new drug called sorafenib (Nexavar) after they’ve had surgery can improve survival.
Investigating cancer risks
In Belfast, Dr Blánaid Hicks is investigating what affects people’s risk of kidney cancer. Some commonly used medications have been suggested to both increase the risk of developing the disease and protect against it. Dr Hicks is investigating these links in more detail. She is also looking at the effects of physical activity and obesity on people’s kidney cancer risk, and whether this differs between different ethnic groups.